WebJun 21, 2024 · Citius Pharmaceuticals, Inc. (NASDAQ:CTXR) is not the most popular stock in this group but hedge fund interest is still above average. Our overall hedge fund sentiment score for CTXR is 59.2. WebIn this section, we analyze the profitability of every unplanned, open-market insider purchase made in CTXR / Citius Pharmaceuticals Inc. This analysis helps to understand if the insider consistently generates …
Citius Pharmaceuticals, Inc. (CTXR) - Stock Analysis
WebApr 4, 2024 · In a report released yesterday, Michael Okunewitch from Maxim Group maintained a Buy rating on Citius Pharmaceuticals (CTXR – Research Report), with a price target of $4.00. The company’s ... WebApr 13, 2024 · Recent Technical Analysis Signals for CTXR - Citius Pharmaceuticals, Inc. CTXR Chart by TradingView Watchlist Portfolio. For Date: Filter for Selected Date Show All Date Name Type % Chg 2024-04-13 ... Twitter SwingTradeBot Australia (ASX) SwingTradeBot Canada (TSX & TSXV) SwingTradeBot London / UK (LSE & AIM) hyde herrera photos
CTXR Stock Price Citius Pharmaceuticals Inc. Stock Quote (U.S ...
WebNov 1, 2024 · Regular YouTube videos on financial market outlooks, news, ERs, stock research, TA, options trading, & investing. NOT FINANCIAL ADVICE. Potato with a platform. WebCTXR Stock Price - Citius Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and commercialization of critical care products, with a focus … Web20 hours ago · Citius Pharmaceuticals (CTXR) (Real Time Quote from BATS) $1.54 USD -0.03 (-1.91%) Updated Apr 13, 2024 02:16 PM ET Add to portfolio Zacks Rank: 4-Sell 4 Style Scores: F Value C Growth D... masonry stain colors